Hai Wu

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

Feng‐Hua Wang, Xiaoli Wei, Jifeng Feng et al. · Journal of Clinical Oncology · 2021 · 351 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Bixia Tang, Xieqiao Yan, Xinan Sheng et al. · Journal of Hematology & Oncology · 2019 · 188 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G₄ Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB Trial

Xinan Sheng, Xieqiao Yan, Zhihong Chi et al. · Journal of Clinical Oncology · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer

Zhe Kong, Xuechao Wan, Yalong Zhang et al. · Biochemical and Biophysical Research Communications · 2017 · 164 citations

Medicine, Molecular Biology, Oncology +14

Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis

Hai Wu, Troy W. Whitfield, Jonathan A. R. Gordon et al. · Genome biology · 2014 · 148 citations · Full text

Medicine, Genetics, Molecular Biology +17